In addition, CCL5+ TAMs within ccRCC tissues exhibited lower levels of immune stimulatory effective molecules (IFNG, PRF1, GZMB, and CD69) and increased expression of immune inhibitory checkpoints (PD-L1, TIM3, TIGIT, LAG3. The gene discussed is IFNG; the disease is nonpapillary renal cell carcinoma.